Schizophrenia

Excellence Forum

Leaders in the field sharing authoritative insights and institutional best practices.

FDA Alerts

Schizophrenia
Schizophrenia
06/06/2017
Aristada recently received approval from the US Food and Drug Administration for a new and shorter dosing regimen, providing more options to patients and health care providers.
06/06/2017